Literature DB >> 6789333

Deposition of plasma fibronectin in tissues.

E Oh, M Pierschbacher, E Ruoslahti.   

Abstract

Tissue distribution of human fibronectin injected intravenously into mice was studied by using immunofluorescence with species-specific antisera to human and mouse fibronectins. Human fibronectin was detected in the tissues of mice injected with human fibronectin. The distribution of the injected fibronectin was indistinguishable from that of mouse fibronectin. The staining for human fibronectin in the livers of injected mice was unaffected by perfusion of the livers prior to the preparation of tissue sections, and human IgG injected in mice as a control was not detectable in tissues by immunofluorescence. Mice were also injected with fragments of fibronectin with molecular weights close to 200,000. These fragments lack parts of the NH2 and COOH termini of the fibronectin polypeptide, including the part with the interchain disulfide bond(s), but retain the ability to bind to collagen and heparin and the ability to mediate cell attachment. They showed essentially no tissue incorporation, suggesting that the integrity of the fibronectin molecule is important for the accumulation of fibronectin in tissues. The incorporation of injected fibronectin into tissues demonstrated here suggests that circulating fibronectin contributes to the extracellular matrix of tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789333      PMCID: PMC319532          DOI: 10.1073/pnas.78.5.3218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Heterogeneity of the cold-insoluble globulin of human plasma (CIg), a circulating cell surface protein.

Authors:  A B Chen; D L Amrani; M W Mosesson
Journal:  Biochim Biophys Acta       Date:  1977-08-23

3.  Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII.

Authors:  J Keski-Oja; D F Mosher; A Vaheri
Journal:  Cell       Date:  1976-09       Impact factor: 41.582

4.  Plasma membrane glycoprotein which mediates adhesion of fibroblasts to collagen.

Authors:  E Pearlstein
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

5.  Similarity of fibronectins isolated from human plasma and spent fibroblast culture medium.

Authors:  M Vuento; M Wrann; E Ruoslahti
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

6.  Extensive disulfide bonding at the mammalian cell surface.

Authors:  R O Hynes; A Destree
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

7.  Isolation and biochemical characterization of alpha-2-opsonic glycoprotein from rat serum.

Authors:  F Blumenstock; P Weber; T M Saba
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

8.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

9.  Fibroblast surface antigen: a new serum protein.

Authors:  E Ruoslahti; A Vaheri; P Kuusela; E Linder
Journal:  Biochim Biophys Acta       Date:  1973-10-18

10.  Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

Authors:  N E Stathakis; M W Mosesson
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more
  58 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures.

Authors:  D M Peters; L M Portz; J Fullenwider; D F Mosher
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

3.  A study on content and distribution of plasma and tissue fibronectin in rats using ELISA and immunofluorescence.

Authors:  H M Jin
Journal:  J Tongji Med Univ       Date:  1990

4.  Fibronectin regulates growth factor signaling and cell differentiation in primary lens cells.

Authors:  Judy K VanSlyke; Bruce A Boswell; Linda S Musil
Journal:  J Cell Sci       Date:  2018-11-20       Impact factor: 5.285

5.  Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha(v) beta3.

Authors:  Z Yun; T W Smith; D G Menter; L V McIntire; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

6.  Differential expression of the extra domain-containing form of cellular fibronectin in human placentas at different stages of maturation.

Authors:  I Virtanen; L Laitinen; T Vartio
Journal:  Histochemistry       Date:  1988

7.  Cryptic activity within the Type III1 domain of fibronectin regulates tissue inflammation and angiogenesis.

Authors:  Christina Cho; Rhiannon Kelsh-Lasher; Anthony Ambesi; Paula J McKeown-Longo
Journal:  Curr Top Pept Protein Res       Date:  2015

8.  Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.

Authors:  A Ortíz; J Alonso; M Gómez-Chiarri; J L Lerma; D Seron; E Condom; E González; J Egido
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Authors:  S Grisanti; K Heimann; P Wiedemann
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

Review 10.  Fibronectin in cell adhesion and invasion.

Authors:  E Ruoslahti
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.